Drug class
Cytolytic Agent; Decreased Cell Membrane Integrity
Mechanism of action
KYBELLA is a cytolytic drug, which when injected into submental fat - in patients with moderate to severe convexity or fullness associated with submental fat - physically destroys the cell membrane causing lysis.
General use cases
- subcutaneous fat outside the submental region, and such use is not recommended [see Warnings and Precautions ( 5
- subcutaneous fat outside the submental region, and such use is not recommended
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
